Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors.
about
Epothilones: From discovery to clinical trialsQuantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MS.Recent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsPhase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.Biosensor-aided high-throughput screening of hyper-producing cells for malonyl-CoA-derived products.
P2860
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I dose escalation study ...... ts with advanced solid tumors.
@en
Phase I dose escalation study ...... ts with advanced solid tumors.
@nl
type
label
Phase I dose escalation study ...... ts with advanced solid tumors.
@en
Phase I dose escalation study ...... ts with advanced solid tumors.
@nl
prefLabel
Phase I dose escalation study ...... ts with advanced solid tumors.
@en
Phase I dose escalation study ...... ts with advanced solid tumors.
@nl
P2093
P2860
P1476
Phase I dose escalation study ...... ts with advanced solid tumors.
@en
P2093
Alison L Hannah
Barbara McCracken
Brandi I Haley
Elaine T Lam
Gillian F Cropp
Larry J Schaaf
Miguel A Villalona-Calero
Robert G Johnson
Sanjay Goel
Sridhar Mani
P2860
P2888
P304
P356
10.1007/S00280-011-1724-7
P577
2011-08-27T00:00:00Z